Tenth Artificial Heart, Tenth New Life: LVAD Program Reaches New Milestone at Our Partner Hospital
The First Affiliated Hospital of Jinan University completed its tenth LVAD implantation for a critically ill truck driver with end-stage heart failure — as experts warn that chronic overwork is also a trigger of heart failure.
Read more →
Dual-Clip DragonFly TEER for Severe Mitral Regurgitation: New Milestone in Structural Heart Intervention
Prof. Peng Yucheng and Prof. Han Wei's teams completed TEER with DragonFly — China's first China-EU dual-certified mitral clip system — implanting two clips in an 82-year-old patient, bringing severe regurgitation down to trace.
Read more →
First in Mainland China: Diamondback 360 Orbital Atherectomy System Lands in Foshan via "HK-Macao Drug & Equipment Connect"
Foshan Chancheng Hospital completed the first mainland-China clinical use of the Diamondback 360 coronary orbital atherectomy system — a dual-effect solution that ablates superficial calcium and loosens deep calcium for severely calcified lesions.
Read more →
75-Gram HeartCon II: China's Smallest Artificial Heart Brings New Hope to End-Stage Heart Failure Patient
A fully magnetically levitated homegrown LVAD weighing only 75 grams was implanted on a beating heart through bilateral mini-incisions — the device now runs steadily and the patient's recovery has exceeded expectations.
Read more →
From Remission to Cure: Long-Term CAR-T Data from China Rewrites Lymphoma Treatment Standards
Five-year follow-up of Axi-cel shows 42.6% overall survival in refractory patients, 65% complete response and 54.6% four-year survival in second-line disease, with consistent Chinese real-world evidence of 83% response.
Read more →
Five Years of Yikaida (Axi-cel): China's First CAR-T Therapy Treats 1,500+ Lymphoma Patients
China's first approved CAR-T cell therapy marks five years: 1,500+ patients treated, its first patient cancer-free for over eight years, 200+ treatment centers in 29 provinces, and a third indication in breakthrough development.
Read more →
World's First Solid-Tumor CAR-T Reaches the Clinic: Bay Area's First Patient T-Cell Collection Completed
Foshan Chancheng Hospital completed the Greater Bay Area's first T-cell collection for sattikecel (CT041), the world's first approved CAR-T for solid tumors, for a gastric cancer patient previously treated in Mongolia and South Korea.
Read more →
Fosun Kairos's Dual-Target CAR-T FKC289 Cleared for Clinical Trials in Rare AL Amyloidosis
The BCMA/CD19 dual-target autologous CAR-T received implicit clinical trial approval for relapsed/refractory primary light chain amyloidosis — a rare disease with scarce treatment options.
Read more →
China's CAR-T Goes Global: Fosun Kairos Signs Strategic MOU with Saudi Arabia's Fakeeh Care Group
The partnership will localize Fosun Kairos's CAR-T cell therapy in Saudi Arabia — covering local manufacturing, registration and commercialization under Vision 2030.
Read more →
Foshan Chancheng Hospital at China-Hospeq 2026: Sharing the Future of International Healthcare
The hospital presented its FIMC center, 60 Hong Kong-Macao device approvals, direct insurance billing and end-to-end international patient services at the Beijing forum.
Read more →
Da Vinci Precision Beyond Borders: Vietnamese Patient’s Robotic Lung Surgery
A da Vinci robotic right lower lobectomy removes a suspicious lung nodule while preserving healthy tissue and minimizing trauma, supported by FIMC international services.
Read more →
“Thank You, China”: Bangladeshi Patient’s 20-Hour Skull-Base Surgery
A multidisciplinary team removed an invasive glomus jugulare tumor spanning the skull base, temporal bone and upper neck—without a blood transfusion.
Read more →
First Iloprost Injection in Foshan: 80-Year-Old Diabetic Foot Patient Avoids Amputation
Foshan Chancheng Hospital gave the first local Iloprost injection under the Greater Bay Area policy, opening a new limb-salvage pathway for severe diabetic foot.
Read more →
Across the Ocean for TCM: Overseas Patient Finds Hope for Chronic Kidney Disease
An overseas patient who had sought care in Singapore came to Foshan Chancheng Hospital for a 10-day integrated TCM program; renal markers and symptoms improved.
Read more →
20-Year-Old Bangladeshi Patient’s Da Vinci Kidney-Sparing Surgery
A 20-year-old woman with TSC-related kidney tumor traveled 2,800 km from Dhaka to Foshan for robot-assisted surgery that preserved her kidney.
Read more →
Across Mountains and Seas, Medicine Connects
A delegation of 14 senior healthcare professionals from seven South Pacific island nations visited FIMC for clinical exchange and TCM experience.
Read more →
National First Batch: Chancheng Implants Leadless "Capsule" Pacemaker
Foshan Chancheng Hospital successfully implanted a leadless "capsule" pacemaker — scar-free, minimally invasive, with a battery life of nearly 17 years.
Read more →
Chancheng TCM Hospital Named a Guangdong High-Level Specialty
The hospital's TCM division was recommended among "2025 Guangdong's Strongest Departments", recognizing its clinical and research excellence.
Read more →
Bringing Care to the Community
Through health-management centers and regular free screenings, Chancheng extends preventive care beyond hospital walls across Foshan.
Learn more →